✦ LIBER ✦

The cost-effectiveness of pharmacist-led treatment of cardiac risk in patients with type 2 diabetes

✍ Scribed by Lowey, Andrew ;Moore, Sara ;Norris, Catherine ;Wright, David ;Silcock, Jonathan ;Hammond, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of pioglitazone on cardiac sympat

✍ F. E. Gianiorio; M. Casu; V. Patrone; C. G. Egan; G. Murialdo 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 284 KB

The burden of type 2 diabetes in Serbia

✍ Vesna Bjegovic; Zorica Terzic; Jelena Marinkovic; Nebojsa Lalic; Sandra Sipetic; 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 140 KB

Audit of vascular risk factor reduction

✍ M. Sherlock; D. Mylotte; J. McMahon; C. J. Thompson; K. B. Moore 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 414 KB

Effects of controlled hypoglycaemia on c

✍ M. L. Koivikko; M. Karsikas; P. I. Salmela; J. S. Tapanainen; A. Ruokonen; T. Se 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 167 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB